MIRA Stock Snapshot
Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
03
Price$0.73
Market Cap (MRQ)$31M
P/E-0.5
EPS$-1.35
ROE-190.5%
52W Range$1–$2
MIRA Stock Price Chart
Daily OHLCV with technical indicators — pan, zoom, and customize your view
04
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance
Revenue, net income, margins and EPS trends
06
EPS$-1.352022-12-31 → 2025-12-31
Net margin-10557.5%2025-12-31 → 2025-12-31
Valuation & Ratios07–12
Valuation
P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
MIRA
5Y avg
Peer Median
Verdict
P/E
-0.55Y avg ≈-1.5
≈-1.5
·
·
P/B (MRQ)
3.8
·
1.9
Overvalued
Price / Cash Flow
-6.6
·
·
·
Price / Tangible Book
2.95Y avg ≈6.1
≈6.1
·
·
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability
Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
MIRA
5Y avg
Peer Median
Verdict
Net Profit Margin
-10557.5%
·
-530.0%
Weak
ROA
-149.0%
·
-52.3%
Weak
ROE
-190.5%
·
-89.8%
Weak
Financial Health
Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
MIRA
5Y avg
Peer Median
Verdict
Current Ratio (MRQ)
200.1
·
2.1
Strong liquidity
Quick Ratio
15.7
·
2.1
Strong liquidity
Growth
Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
MIRA
5Y avg
Peer Median
Verdict
Revenue YoY
-40.3%
·
·
·
Per Share Metrics
EPS, book value per share, cash flow per share, dividend per share
Metric
5Y trend
MIRA
5Y avg
Peer Median
Verdict
EPS (Diluted)
$-1.355Y avg ≈$-0.78
≈$-0.78
·
·
Cash / Share
$0.15
·
·
·
Capital Efficiency
Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
MIRA
5Y avg
Peer Median
Verdict
Asset Turnover
0.0
·
0.1
Weak
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History
EPS actual vs estimate, surprise %, beat rate, next earnings date
14
Avg Surprise30.4%
Next ReportNov 11, 2026
Period
Report
EPS Actual
EPS Est
Surprise
June 30, 2026
Aug 12, 2026
$-0.03
—
—
Sept. 30, 2025
$-0.06
$-0.08
26.5%
June 30, 2025
$-0.09
$-0.13
32.1%
March 31, 2025
$-0.11
$-0.15
25.6%
Dec. 31, 2024
$-0.15
$-0.24
37.4%
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
15
Income Statement10
Metric
Trend
2025
2024
2023
2022
R&D Expense
$2M
$3M
$2M
$2M
SG&A Expense
$9M
$5M
$6M
$3M
Operating Expenses
$10M
$8M
$9M
$7M
Interest Expense
·
$-165.7K
$3M
$10.2K
Other Non-op
$50.6K
$165.7K
·
·
Net Income
$-10M
$-8M
$-12M
$-7M
EPS (Basic)
$-1.35
$-0.51
$-0.85
$-0.40
EPS (Diluted)
$-1.35
$-0.51
$-0.85
$-0.40
Shares (Basic)
23,694,333
15,444,149
13,924,619
17,566,533
Shares (Diluted)
·
15,444,149
13,924,619
17,566,533
Balance Sheet16
Metric
Trend
2025
2024
2023
2022
Cash & Equivalents
$6M
$3M
$5M
$351.0K
Short-term Investments
$5M
·
·
·
Prepaid Expense
$28.1K
$54.7K
$243.8K
·
Current Assets
$11M
$3M
$5M
$494.4K
Total Assets
$11M
$3M
$5M
$858.1K
Accounts Payable
$129.2K
$723.3K
$538.6K
$811.7K
Accrued Liabilities
·
$300.0K
·
·
Current Liabilities
$702.1K
$723.3K
$558.1K
$1M
Capital Leases
·
·
·
$84.3K
Total Liabilities
$702.1K
$723.3K
$558.1K
$1M
Common Stock
$4.2K
$1.7K
$1.5K
$6.7K
Paid-in Capital
$50M
$31M
$26M
$9M
Retained Earnings
$-40M
$-29M
$-21M
$-9M
Stockholders' Equity
$10M
$2M
$4M
$-596.2K
Liabilities + Equity
$11M
$3M
$5M
$858.1K
Shares Outstanding
41,938,587
16,560,852
14,780,885
13,313,000
Cash Flow6
Metric
Trend
2025
2024
2023
2022
Stock-based Comp
$6M
$2M
$3M
$1M
Operating Cash Flow
$-5M
$-6M
$-5M
$-6M
Stock Issued
$7M
$4M
$8M
$3M
Net Stock Activity
$7M
·
$8M
·
Financing Cash Flow
$8M
$4M
$9M
$3M
Net Change in Cash
$4M
$-2M
$4M
$-2M
Profitability3
Metric
Trend
2025
2024
2023
2022
Net Margin
-10557.5%
·
·
·
ROA
-149.0%
·
-413.9%
·
ROE
-190.5%
·
-634.3%
·
Liquidity & Solvency2
Metric
Trend
2025
2024
2023
2022
Current Ratio
15.8
·
8.7
·
Quick Ratio
15.7
·
8.2
·
Efficiency1
Metric
Trend
2025
2024
2023
2022
Asset Turnover
0.0
·
·
·
Per Share4
Metric
Trend
2025
2024
2023
2022
Book Value / Share
$0.25
·
$0.30
·
Cash Flow / Share
·
·
$-0.24
·
Cash / Share
$0.15
·
$0.31
·
EPS (TTM)
$-1.35
$-0.51
$-0.85
·
Growth Rates1
Metric
Trend
2025
2024
2023
2022
Revenue YoY
-40.3%
·
·
·
Valuation (TTM)7
Metric
Trend
2025
2024
2023
2022
Net Income TTM
$-10M
$-8M
$-12M
·
Market Cap
$63M
·
$16M
·
P/E
-1.1
-2.2
-1.2
·
P/B
6.1
·
3.5
·
P / Tangible Book
6.1
8.6
3.5
·
P / Cash Flow
-13.6
·
-3.4
·
Earnings Yield
-89.4%
-44.7%
-81.0%
·
Income Statement10
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
R&D Expense
$705.8K
$524.8K
$496.5K
$412.6K
$496.2K
$314.4K
$861.4K
$1M
$614.5K
$762.3K
$387.1K
$1M
$-101.0K
$271.6K
$884.8K
$715.0K
SG&A Expense
$450.3K
$578.7K
$5M
$904.3K
$1M
$1M
$2M
$1M
$1M
$1M
$3M
$2M
$1M
$614.2K
$51.7K
$736.1K
Operating Expenses
$1M
$1M
$6M
$1M
$2M
$2M
$2M
$2M
$2M
$2M
$3M
$3M
$970.2K
$1M
$1M
$2M
Interest Expense
·
·
·
·
·
$-21.4K
·
$-37.8K
$-39.4K
$-50.4K
$3M
$427.7K
$295.9K
$1.7K
$1.8K
$2.3K
Other Non-op
$-52.4K
$-46.7K
$-158.5K
$179.3K
$8.4K
$21.4K
$38.1K
$37.8K
·
·
·
·
·
·
·
·
Net Income
$-1M
$-1M
$-6M
$-1M
$-2M
$-2M
$-2M
$-2M
$-2M
$-2M
$-6M
$-4M
$-1M
$-1M
$-1M
$-2M
EPS (Basic)
$-0.03
$-0.03
$0.03
$-1.18
$-0.09
$-0.11
$-0.11
$-0.14
$-0.11
$-0.15
$-0.39
$-0.26
$-0.10
$-0.10
$0.03
$-0.14
EPS (Diluted)
$-0.03
$-0.03
$0.03
$-1.18
$-0.09
$-0.11
$-0.11
$-0.14
$-0.11
$-0.15
$-0.39
$-0.26
$-0.10
$-0.10
$0.03
$-0.14
Shares (Basic)
42,022,087
41,941,370
·
19,274,947
16,986,488
16,645,119
·
15,071,915
14,780,885
14,780,885
·
13,639,197
13,313,000
17,750,667
·
13,168,556
Shares (Diluted)
·
·
·
19,274,947
16,986,488
16,645,119
·
15,071,915
14,780,885
14,780,885
·
13,639,197
13,313,000
17,750,667
·
13,168,556
Balance Sheet16
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Cash & Equivalents
$4M
$5M
$6M
$3M
$730.5K
$1M
$3M
$4M
$3M
$4M
$5M
$6M
$24.8K
·
$351.0K
·
Short-term Investments
$5M
$5M
$5M
$5M
·
·
·
·
·
·
·
·
·
·
·
·
Prepaid Expense
$54.3K
$21.7K
$28.1K
$61.9K
$102.4K
$158.6K
$54.7K
$86.6K
$108.6K
$185.3K
$243.8K
$202.8K
$42.5K
·
·
·
Current Assets
$8M
$9M
$11M
$8M
$832.9K
$1M
$3M
$4M
$3M
$4M
$5M
$6M
$420.7K
·
$494.4K
·
Total Assets
$8M
$9M
$11M
$8M
$868.3K
$1M
$3M
$4M
$3M
$4M
$5M
$9M
$4M
·
$858.1K
·
Accounts Payable
$40.8K
$34.0K
$129.2K
$83.9K
$298.5K
$100.7K
$723.3K
$692.8K
$782.1K
$636.3K
$538.6K
$779.6K
$659.1K
·
$811.7K
·
Accrued Liabilities
·
·
·
·
·
$5.5K
·
·
·
·
·
·
·
·
·
·
Current Liabilities
$40.8K
$114.8K
$702.1K
$83.9K
$298.5K
$106.2K
$723.3K
$692.8K
$796.6K
$652.0K
$558.1K
$868.4K
$3M
·
$1M
·
Capital Leases
·
·
·
·
·
·
·
·
·
·
·
$34.5K
$51.5K
·
$84.3K
·
Total Liabilities
$40.8K
$114.8K
$702.1K
$83.9K
$298.5K
$106.2K
$723.3K
$692.8K
$796.6K
$652.0K
$558.1K
$902.9K
$3M
·
$1M
·
Common Stock
$4.2K
$4.2K
$4.2K
$4.0K
$1.7K
$1.7K
$1.7K
$1.6K
$1.5K
$1.5K
$1.5K
$1.5K
$6.7K
·
$6.7K
·
Paid-in Capital
$50M
$50M
$50M
$41M
$33M
$32M
$31M
$30M
$27M
$26M
$26M
$24M
$13M
·
$9M
·
Retained Earnings
$-42M
$-41M
$-40M
$-34M
$-32M
$-31M
$-29M
$-27M
$-25M
$-23M
$-21M
$-15M
$-12M
·
$-9M
·
Stockholders' Equity
$8M
$9M
$10M
$8M
$569.9K
$1M
$2M
$4M
$2M
$3M
$4M
$8M
$1M
·
$-596.2K
·
Liabilities + Equity
$8M
$9M
$11M
$8M
$868.3K
$1M
$3M
$4M
$3M
$4M
$5M
$9M
$4M
·
$858.1K
·
Shares Outstanding
42,022,087
42,022,087
41,938,587
39,511,492
17,385,140
16,813,654
16,560,852
16,266,148
14,780,885
14,780,885
14,780,885
14,780,885
13,313,000
·
13,313,000
·
Cash Flow6
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Stock-based Comp
$21.9K
$107.6K
$5M
$390.8K
$489.6K
$874.8K
$546.8K
$269.0K
$604.8K
$500.2K
$213.8K
$1M
$737.2K
$147.8K
$147.8K
$147.8K
Operating Cash Flow
$-1M
$-1M
$-1M
$-1M
$-799.7K
$-2M
$-2M
$-2M
$-863.9K
$-1M
$-1M
$-2M
$-660.8K
$-1M
$-975.4K
$-1M
Stock Issued
·
·
$4M
$3M
$345.3K
$3.4K
$478.9K
·
·
·
$0
·
·
·
$285.0K
$900.0K
Net Stock Activity
·
·
·
·
·
$3.4K
·
·
·
·
·
·
·
·
·
·
Financing Cash Flow
$0
$-330.6K
$5M
$3M
$323.8K
$3.4K
$493.4K
$3M
$159.0K
$-24.3K
$-230.7K
$8M
$684.3K
$725.7K
$1M
$676.4K
Net Change in Cash
$-1M
$-2M
$4M
$2M
$-475.8K
$-2M
$-1M
$1M
$-704.9K
$-1M
$-1M
$6M
$23.5K
$-349.6K
$163.6K
$-638.6K
Profitability3
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Net Margin
-3440.2%
-2561.1%
·
-7247.7%
·
·
·
·
·
·
·
·
·
·
·
·
ROA
-26.6%
-21.2%
·
-19.1%
-79.2%
-68.5%
·
-30.8%
-49.5%
-90.2%
·
-79.6%
-66.2%
·
·
·
ROE
-27.7%
-21.6%
·
-20.5%
-110.3%
-80.2%
·
-35.0%
-99.0%
-108.8%
·
-88.4%
-211.6%
·
·
·
Liquidity & Solvency2
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Current Ratio
200.1
82.2
·
90.5
2.8
12.9
·
6.1
3.7
5.7
·
7.0
0.2
·
·
·
Quick Ratio
198.7
82.0
·
89.8
2.4
11.4
·
6.0
3.5
5.4
·
6.8
0.0
·
·
·
Efficiency1
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Asset Turnover
0.0
0.0
·
0.0
·
·
·
·
·
·
·
·
·
·
·
·
Per Share5
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Book Value / Share
$0.19
$0.22
·
$0.19
$0.03
$0.08
·
$0.22
$0.15
$0.21
·
$0.55
$0.09
·
·
·
Revenue / Share
·
·
·
$0.00
·
·
·
·
·
·
·
·
·
·
·
·
Cash Flow / Share
·
·
·
·
·
$-0.10
·
·
·
$-0.05
·
·
·
·
·
·
Cash / Share
$0.09
$0.11
·
$0.07
$0.04
$0.07
·
$0.25
$0.19
$0.24
·
$0.40
$0.00
·
·
·
EPS (TTM)
$-1.21
$-1.27
·
$-1.49
$-0.45
$-0.47
·
$-0.79
$-0.91
$-0.90
·
$-0.43
$-0.31
$-0.40
·
·
Valuation (TTM)7
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Net Income TTM
$-9M
$-10M
·
$-7M
$-8M
$-8M
·
$-11M
$-13M
$-12M
·
$-8M
$-6M
$-7M
·
·
Market Cap
$40M
$45M
·
$54M
$21M
$16M
·
$21M
$9M
$16M
·
$69M
·
·
·
·
P/E
-0.8
-0.8
·
-0.9
-2.7
-2.1
·
-1.6
-0.7
-1.2
·
-10.8
·
·
·
·
P/B
4.9
4.8
·
7.1
36.9
12.7
·
5.9
4.2
5.2
·
8.5
·
·
·
·
P / Tangible Book
4.9
4.8
·
7.1
36.9
12.7
·
5.9
4.2
5.2
·
8.5
·
·
·
·
P / Cash Flow
·
-37.4
·
·
·
-10.1
·
·
·
-15.5
·
·
·
·
·
·
Earnings Yield
-127.8%
-118.7%
·
-109.6%
-37.2%
-48.0%
·
-60.8%
-142.9%
-81.8%
·
-9.2%
·
·
·
·
Most recent period on the left · null values shown as ·
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
16
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Net Income
$-10M
$-8M
$-12M
$-7M
Diluted EPS
$-1.35
$-0.51
$-0.85
$-0.40
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Current Ratio
15.8
·
8.7
·
Quick Ratio
15.7
·
8.2
·
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F)
27 filers
· $3.2M total
· As of June 30, 2026
17
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders27
Value held$3.2M
New positions4
Exited positions4
Institutional activity — Q2 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
4 (-4 vs prior Q)
4 (-1 vs prior Q)
6 (0 vs prior Q)
6 (+5 vs prior Q)
+168K
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
Filer
Filed
Stake
Status
Purpose
Filing
Brian McNulty, Individually and as Trustee of the Bay Shore Trust, Bay Shore Trust
×3 filings
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders
9 insiders
· 3 officers · 8 directors